Company: STAA
Filing Date: 2025-11-06
Form Type: DFAN14A
Source: 0001213900-25-107231
Chunk: 5

Company: STAAR SURGICAL CO
Filing Date: 2025-11-06
Form: DFAN14A
Chunk 5
---
 or Japan.” The report also observed that Chinese consumers are “willing to spend again,” with retail
sales growing 5% year-on-year in the first half of 2025, propelled by “a surge in innovation and shifting consumer behavior”
and beating market expectations.

<div align='center'>3</div>

In another instance of selective quotation, Alcon’s presentation
copies a chart from the report showing certain negative trend data from the Chinese Consumer Confidence Index. But the report fails to
relate McKinsey’s own take on the same data, where they observe, “Yet beyond these headlines, consumers appear to have quietly
moved on ... Retail sales are climbing in key categories.” McKinsey & Co also found that “foreign brands continue to find
fertile ground for scaling in China.” This overall outlook set forth in the report is in contrast to Alcon’s own attempt to
paint a dire economic outlook for the China market and to underplay STAAR’s mid- to long-term growth potential.

Board Composition

We also believe the Board would benefit from additional shareholder
perspective and the presence of a director with meaningful economic ownership. As noted previously, I would be pleased to serve on the
Board to provide that perspective and would welcome a discussion.

It is telling that Alcon’s presentation urges STAAR shareholders
to support the proposed merger — purportedly in STAAR shareholders’ best interests — while expressing no support for,
and implicitly opposing, my offer to be considered by the Board for membership. Yunqi is one of the Company’s largest shareholders
and has a deep understanding of the Chinese market, sustained conviction in STAAR’s products, and full alignment with shareholder
interests.

It is time to listen to shareholders either way. A reported 72% of outstanding STAAR shares resoundingly voted the transaction as of the originally
scheduled special meeting date of October 23. We take this figure to be accurate, as neither STAAR nor Alcon has disputed
it since the initial report on October 24. Shareholders already knew what they needed to know as of October 23, and the Company’s
latest earnings news only reinforces what was already clear to those who voted against the merger.

With all of this said, we continue to be available to work constructively
with you and management to realize the significant value that STAAR can create. We remain confident in STAAR’s long-term prospects
and its ability to deliver strong revenue growth and profitability.

Sincerely,

Christopher M. Wang
Founder and